Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
With those last 2 amounts;How on Earth are PXS still making a loss?
In fact, our annual loss has been less than the PSA income for last couple of years.
Don't need to see much of an uplift with DSM gone to be in profit
https://postimg.cc/HVJyZ1B4
W$
Krusty
DSM have been making a profit on FF for the last 7 years. Our share of the psa profit is detailed below (keep up)
01/03/2022 £282,000
01/03/2021 £358,000
01/03/2020 £233,000
01/03/2019 £192,000
01/03/2018 £162,000
01/03/2017 £153,000
01/03/2016 £92,000
W$
I hope you are right Sphinx.
Krusty, in short, none of us know. All we know is that DSM continued to invest money into FF research.
PXS make it ambiguous. When talking about DSM they talk of FF prospective pipeline standing at significant multiples, but it is not clear whether they are including BH in that. Some think it applies to DSM only, which would only require 1 larger customer or 2.
Hopefully things will become clearer, but as it stands they are purposefully ambiguous.
All deliberately ambiguous in my opinion , what I take it to mean is multiples between 3x and 9 x , but significant to me means up to 30x or 40x ,but it is open to each persons interpretation imo
The "significant multiple" repeated theme is in the context of the potential Chinese market, not related to the DSM agreement, so we'll see no huge jump in profit this year.
Turnover is tiny here (£179k half-year to 30/9) leading to significant losses again (£157,634 half-year to 30/9). The only thing that will move us away from this situation is volume, plain & simple. Some on here still believe that volume will come from the DSM alliance - I don't. In my view the only thing that can take us to the next level (break-even) and beyond (significant profits) is the By-Health connection. The sooner we get some positive news on that front the better.
gixer - "Fruitflow was definitely making a profit from being sold in 55 countries." Really? How so?? And where is the evidence for this?
I hope it was extremely unfair to PXS, meaning that we will start to see a huge jump in profit now.
For all these years we have had meaningless updates like 'significant multiples of current FF sales', when we don't know what FF sales are and don't know what significant multiples means. Hopefully that ends this year, we should at least know what the FF sales are. We'll get a glimpse end of Sept, then a much better idea at the end of Dec. In the meantime we sit and wait for positive news updates.
I decided that significant multiples means 5x at an absolute minimum.
Multiple - 2x to 4x
Significant multiples > 5x
But I hope I'm wrong and between 5x and 10x they would say 'large multiples'.
What do other understand these expressions to mean?
Well we’ll find out later this year how much DSM we’re taking out of the AA agreement and if it was fair to pxs
No but Fruitflow was definitely making a profit from being sold in 55 countries.
PXS have not made a profit Yet
Maybe we don’t have to pay DSM anything for the next 4 years as we can’t make a profit :)
As highlighted by Duttaroy in the Bangladesh article, it used to cost 600 per KG to produce, but now costs 150. This will certainly drop much further when the volume dramatically increases.
The whole model changed on Jan 1st, then BH volumes will be massively beneficial to future margins.
Mmm!
If Fruitflow "cannot make a profit" please tell me how PXS got a share of it.
Sold in 55 countries:and still cannot make a profit:Hopefully will do soon
"Brief CV of Professor Asim K. Duttaroy"
I like how he managed to keep it down to 15 pages :)
Dr H when orders start coming in from By health as you say we could get multiple orders of maybe £4-5 m at that early stage I believe an Rns should be issued with each order as the amount will be a multiple of current revenue and notifiable ,things will become clearer .imo
Dr H,
Great post with lots of optimism. I agree with you it will be very nice if we get a good dividend and then a big payout. Hope the oldies like Unilever and Coke will be on board once BH start rolling out new products.
Yeh there is no volume at present, the share is dead. It will gain attention with China news and actual results / money in the bag.
At the end of the day we have no idea what is going to happen. Perhaps I am being far too bullish, but all the information we have seems to be very bullish.
It will be September before we perhaps get a view of income from old DSM customers, perhaps even year end.
Optimism at this scale hasn't been expressed here previously without attracting the attention of the bashing crew. From the evidence presented it does appear that this time the potential can be more fully appreciated. Fruitflow is a product that will soon have truly global reach, with the support of serious promotional activity. I share your view Dr H, wouldn't want a buy out to occur just as the long road to rapid commercial expansion appears to have reached an inflexion point. Not that we PI's will have much say in the matter. the only thing missing at present is share buying volume. Seems that many are awaiting real, tangible reports.
Relevant to the earlier conversation about why it takes so long.
https://www.cirs-group.com/en/food/products-with-the-new-health-function-claims-are-being-possible-in-china
DP64,
I think you underestimate the potential value of PXS. A share value of 9p would only give a market cap of around £200m. That would usually be the price of a standard company that makes around £10m.
PXS will soon be a rapid growth company that will report profit perhaps this year, definitely next year. To date PXS share price has been kept low due to lack of financial transparency, lack of meaningful growth forecast, lack of money to sustain any further losses, the constant threat of more drawdowns, terrible write ups from supposedly knowledgeable people that every time fail to understand FF and it’s potential.
As of Jan 01st this year that should have changed. All Fruitflow will be produced and sold by PXS. We should see exactly what total revenue is coming in and what the costs are. We may even get financial forecasts, but maybe that’s too hopeful.
I would imagine, basing my guess on current stock levels, that the CURRENT total FF sales revenues will be around £5m. The initial BH orders will be multiple of that, so at least £10m.
Then we can expect BH and BH Distribution customers to drive significant growth. Followed in a few years by development of FF-based drugs.
The DSM prospective customers are the ones that are in the process of developing products. This is said to be significant and potentially multiples of current income.
DSM premix and gut health is a huge opportunity, but we need to see how that develops.
Square Pharmaceuticals will also likely drive significantly growth.
We could find the market cap being 500m in the next few years.
SIS reached circa £100m after it reported a £1m profit, the first profit ever recorded.
I don’t want the company to be purchased and this significant growth to be stolen away from us. I want us to be sitting here in 5 years admiring the progress and getting lots of dividends.
An update has got to come at some point in the near future.
I'm more interested in whether IF updates us next week re status of DSM stock.
W
W$
Guys,
Many thanks for the thoughtful posts. Hope we will hit 6P with all the new lines of product and then BH offer comes to buy us at 9P.